You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Colorcon
McKinsey
Mallinckrodt
Moodys

Last Updated: April 5, 2020

DrugPatentWatch Database Preview

GOSERELIN ACETATE - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for goserelin acetate and what is the scope of patent protection?

Goserelin acetate is the generic ingredient in one branded drug marketed by Tersera Theraps Llc and is included in two NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Goserelin acetate has fifty patent family members in thirty-three countries.

There are five drug master file entries for goserelin acetate. Three suppliers are listed for this compound.

Recent Clinical Trials for GOSERELIN ACETATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Eulji University HospitalPhase 4
Wonju Severance Christian HospitalPhase 4
Bristol-Myers SquibbPhase 2

See all GOSERELIN ACETATE clinical trials

Recent Litigation for GOSERELIN ACETATE

Identify potential future generic entrants

District Court Litigation
Case NameDate
ADAMAS PHARMA, LLC v. SANDOZ INC.2018-05-10

See all GOSERELIN ACETATE litigation

Pharmacology for GOSERELIN ACETATE
Medical Subject Heading (MeSH) Categories for GOSERELIN ACETATE
Synonyms for GOSERELIN ACETATE
1-9-Luteinizing hormone-releasing factor (swine), 6-(O-(1,1-dimethylethyl)-D-serine)-, 2-(aminocarbonyl)hydrazide, acetate (salt)
1-9-Luteinizing hormone-releasing factor (swine), 6-[O-(1,1-dimethylethyl)-D-serine]-, 2-(aminocarbonyl)hydrazide, acetate (1:)
145781-92-6
6YUU2PV0U8
781G926
BDBM50247974
CAS-145781-92-6
CG-048
CHEMBL1200501
CS-4509
D00573
DSSTox_CID_26736
DSSTox_GSID_46736
DSSTox_RID_81865
DTXSID9046736
Fertilan
Goserelin (acetate)
Goserelin acetate (JAN/USP)
Goserelin acetate [JAN]
Goserelin acetate, >=99% (HPLC), white powder
Goserelin acetate, United States Pharmacopeia (USP) Reference Standard
Goserelin for NMR identification, European Pharmacopoeia (EP) Reference Standard
Goserelin, European Pharmacopoeia (EP) Reference Standard
HY-13673A
IKDXDQDKCZPQSZ-JHYYTBFNSA-N
NCGC00167588-02
NCGC00183275-01
Novgos
Q27265738
SCHEMBL6094
Tox21_112579
Tox21_112937
UNII-6YUU2PV0U8
Zoladex
Zoladex (TN)
Zoladex LA

US Patents and Regulatory Information for GOSERELIN ACETATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tersera Theraps Llc ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Tersera Theraps Llc ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 019726-001 Dec 29, 1989 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Tersera Theraps Llc ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 019726-001 Dec 29, 1989 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Tersera Theraps Llc ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for GOSERELIN ACETATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Tersera Theraps Llc ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996   Start Trial   Start Trial
Tersera Theraps Llc ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 019726-001 Dec 29, 1989   Start Trial   Start Trial
Tersera Theraps Llc ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996   Start Trial   Start Trial
Tersera Theraps Llc ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Colorcon
McKinsey
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.